Laura Van Lieshout,Sarah Wootton,Bradley G. Thompson
申请号：
US16185598
公开号：
US20200148762A1
申请日:
2018.11.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure relates to the composition of one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for upregulating production of two or more antibodies, one or more bi-specific antibodies, or combinations thereof. Embodiments of the present disclosure can be used as a therapy or a treatment of a conditions including: sepsis, parasites, and active and chronic infections caused by bacteria, non-hemorrhagic viruses, amoeba, mycoplasma, fungus, prions or combinations thereof.
